MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/ijgc-2022-003745

Медицинская библиотека · International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2023

Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study.

Imterat Majdi, Bizzarri Nicolò, Fruscio Robert, Perrone Anna Myriam, Traut Alexander, du Bois Andreas, Rosati Andrea, Ferrari Debora, De Iaco Pierandrea, Ataseven Beyhan, Ergasti Raffaella, Volontè Silvia, Tesei Marco, Heitz Florian, Perri Maria Teresa, Concin Nicole, Fanfani Francesco, Scambia Giovanni, Fagotti Anna, Harter Philipp

Наблюдательное исследованиеМногоцентровое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

This international study aimed to investigate the impact of substage, histological type and other prognostic factors on long-term survival for stage I ovarian carcinoma.

METHODS

Our study was a retrospective multicenter cohort study that included patients with the International Federation of Gynecology and Obstetrics (FIGO) stage I (IA-IC3) ovarian carcinoma treated at four European referral centers in Germany and Italy. Using Kaplan-Meier survival curves we compared overall and disease-free survival between the different stage I groups.

RESULTS

A total of 1115 patients were included. Of these, 48.4% (n=540) were in stage IA, 6.6% (n=73) stage IB, and 45% (n=502) stage IC, of the latter substage IC1, 54% (n=271), substage IC2, 31.5% (n=158), and substage IC3, 14.5% (n=73). Five-year overall and disease-free survival rates for the entire cohort were 94% and 86%, respectively, with no difference between stage IA and IB. However, there was a significantly better overall and disease-free survival for stage IA as compared with stage IC (p=0.007 and p<0.001, respectively). Multivariate analysis revealed incomplete/fertility-sparing staging (HR 1.95; 95% CI 1.27 to 2.99, and HR 3.54; 95% CI 1.83 to 6.86, respectively), and stage IC (HR 2.47; 95% CI 1.63 to 3.75) as independent risk factors for inferior disease-free survival, while low-grade endometrioid (HR 0.42; 95% CI 0.25 to 0.72) and low-grade mucinous (HR 0.17; 95% CI 0.06 to 0.44) histology had superior disease-free survival. Considering overall survival, stage IC (HR 2.41; 95% CI 1.45 to 4.01) and older age (HR 2.41; 95% CI 1.46 to 3.95) were independent risk factors.

CONCLUSION

Although stage I ovarian carcinoma exhibited excellent outcomes, the prognosis of patients with stage IA differs significantly compared with stage IC. Sub-optimal staging as an indicator for quality of care, and tumor biology defined by histology (low-grade endometrioid/mucinous) independently impact disease-free survival.

Для цитирования: Imterat Majdi, Bizzarri Nicolò, Fruscio Robert, Perrone Anna Myriam, Traut Alexander, du Bois Andreas, Rosati Andrea, Ferrari Debora, De Iaco Pierandrea, Ataseven Beyhan, Ergasti Raffaella, Volontè Silvia, Tesei Marco, Heitz Florian, Perri Maria Teresa, Concin Nicole, Fanfani Francesco, Scambia Giovanni, Fagotti Anna, Harter Philipp. Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2023. DOI: 10.1136/ijgc-2022-003745.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.